The aim is to investigate the relationship between immune checkpoint inhibitors and various autoimmune bullous diseases.
Review of cases related to immune checkpoint inhibitor use and autoimmune bullous diseases.
Focus on conditions beyond bullous pemphigoid.
Analysis of clinical manifestations and treatment responses.
Identified several autoimmune bullous conditions associated with immune checkpoint inhibitors.
Confirmed the prevalence of these conditions beyond just bullous pemphigoid.
Noted variations in treatment responses and clinical outcomes among affected individuals.
Resumen
The authors declare no conflicts of interest. Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
Me gusta
Guardar
Compartir
Me gusta
Guardar
Compartir
Cite This Study
Koumprentziotis et al. (Wed,) studied this question.